Global Cannabis Industry News | Cannabiz

Trump reclassifies cannabis in the US in ‘global validation moment’ for the plant’s medical potential

by Steve Jones December 19, 2025December 22, 2025

Cannabis will finally be reclassified as a schedule III drug in the US in what is […]

Martin Lane - Cannabis Australia - Cannabiz

Cannabiz is five – where do we go from here?

by Martin Lane July 15, 2025July 15, 2025

Inside Germany’s medicinal cannabis market: regulation, growth and global opportunity

by Adam Sheldon July 10, 2025July 10, 2025

Tasmanian Botanics and AMCA the big winners at the Cannabiz Awards 2025

by cannabiz team May 23, 2025May 26, 2025

Cannabiz strengthens editorial team with key appointments

by cannabiz team May 19, 2025May 19, 2025

Cannabiz Awards 2025: ticket sales close on Friday

by cannabiz team May 13, 2025May 13, 2025

Tickets selling fast for the Cannabiz Awards 2025

by cannabiz team April 30, 2025April 30, 2025

Tickets on sale for the Cannabiz Awards 2025, MC announced

by cannabiz team April 16, 2025April 16, 2025

Cannabiz Awards 2025 shortlist announced after record number of entries

by cannabiz team April 10, 2025April 15, 2025

News in brief: Rua’s German stock shortage; Zelira’s finance deal; cultivator nets $1.4m; Neurotech exec steps down; ‘major milestone’ for Argent; Cann Group pharmacy deal

by Steve Jones and Martin Lane April 3, 2025April 3, 2025